Showing results (231-240 of 831) with videos related to

Sort By:
Pageof 84
Diabetes, Obesity & Metabolism|July 28, 2026
Impact of Albuminuria-Lowering Treatments on Cardiovascular Predictive Ceramides in Diabetes: Post Hoc Analysis of the ROTATE TrialsKristina Pigsborg, Simon Maria Kienle, Asger Wretlind, et al.
Diabetes Care|January 28, 2021
Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER TrialFrederik Persson, Stephen C Bain, Ofri Mosenzon, et al.
European Journal of Endocrinology|January 16, 2007
An IGF-I gene polymorphism modifies the risk of developing persistent microalbuminuria in type 1 diabetesPeter Hovind, Steven Lamberts, Wim Hop, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 28, 2014
Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy TrialCiaran J McMullan, Hiddo J Lambers Heerspink, Hans-Henrik Parving, et al.
Diabetes Care|April 30, 2008
Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 studyPeter Gaede, William J Valentine, Andrew J Palmer, et al.
Diabetes|March 28, 2002
Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of deathCoen D A Stehouwer, Mari-Anne Gall, Jos W R Twisk, et al.
Kidney International. Supplement|March 2, 2011
Need for better diabetes treatment for improved renal outcomePeter Rossing, Dick de Zeeuw
Diabetes, Obesity & Metabolism|July 4, 2020
Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the LEADER randomized trialOfri Mosenzon, Stephen C Bain, Hiddo J L Heerspink, et al.
Free Radical Research|May 12, 2023
Effects of two- and twelve-weeks sodium-glucose cotransporter 2 inhibition on DNA and RNA oxidation: two randomized, placebo-controlled trialsEmil List Larsen, Andreas Andersen, Laura K Kjær, et al.
Immunologic Research|June 21, 2015
Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral lociBjørn A Nexø, Palle Villesen, Kari K Nissen, et al.
Pageof 84